Virtu Financial’s Clovis Oncology, Inc. CLVS Stock Holding History

Virtu Financial’s Portfolio CLVS Stock Details CLVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-53,447	Closed	-$64K	–	2495
2022 Q3	$64K	Buy	+53,447	New	+$83.3K	0.01%	1158
2022 Q1	–	Sell	-64,126	Closed	-$174K	–	2364
2021 Q4	$174K	Sell	64,126 -41,436	-39%	-$153K	0.02%	888
2021 Q3	$471K	Sell	105,562 -66,432	-39%	-$320K	0.04%	494
2021 Q2	$998K	Buy	+171,994	New	+$1.01M	0.1%	202
2020 Q4	–	Sell	-85,075	Closed	-$496K	–	1916
2020 Q3	$496K	Buy	+85,075	New	+$509K	0.09%	291
2019 Q4	$256K	Buy	+24,572	New	+$179K	0.02%	780
2019 Q2	–	Sell	-8,669	Closed	-$215K	–	1998
2019 Q1	$215K	Buy	+8,669	New	+$217K	0.01%	968
2017 Q4	–	Sell	-8,209	Closed	-$676K	–	3188
2017 Q3	$676K	Buy	+8,209	New	+$651K	0.03%	682

Other funds holding CLVS

IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

CAS

Coppell Advisory Solutions Coppell, Texas $170M AUM 13.42% 1-Year Est. Return

CASC

Coppell Advisory Solutions Corp Coppell, Texas $531M AUM

STB

S&T Bank Indiana, Pennsylvania $268M AUM 39.92% 1-Year Est. Return

MCM

MAI Capital Management Independence, Ohio $17.7B AUM 18.87% 1-Year Est. Return

Wedbush Securities Los Angeles, California $3.43B AUM 24.13% 1-Year Est. Return

FFWM

Future Financial Wealth Management Cincinnati, Ohio $155M AUM 13% 1-Year Est. Return

NFSG

Newbridge Financial Services Group Boca Raton, Florida $608M AUM 31.28% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

Virtu Financial's CLVS Position: Q4 2022 in Review

Virtu Financial sold out of Clovis Oncology, Inc. (CLVS) in Q4 2022, closing a stake of 53,447 shares — an estimated $64K sold.

Virtu Financial first reported a position in CLVS in Q3 2017 and held it in 8 quarters. The position peaked at $998K in Q2 2021. 15 funds tracked by Wall St. Rank hold CLVS as of Q4 2022.

Virtu Financial reported no remaining Clovis Oncology, Inc. position as of Q4 2022 after selling out during the quarter.
Virtu Financial sold 53,447 Clovis Oncology, Inc. shares in Q4 2022, an estimated $64K.
Virtu Financial first reported a position in Clovis Oncology, Inc. in Q3 2017 and held it in 8 quarters.
Virtu Financial's Clovis Oncology, Inc. position peaked at $998K in Q2 2021.
15 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q4 2022.

Based on Virtu Financial's 13F filing for Q4 2022, filed 15 Feb 2023.